Intermittent Fasting and Menopause: What the Evidence Can Support

Time-restricted eating is a meal-timing pattern, not a menopause treatment. The women-specific studies are small or short and do not establish an ideal schedule or long-term safety for every reader.

The evidence is bounded

An eight-week secondary analysis included 13 premenopausal and 19 postmenopausal women with obesity; perimenopausal women were excluded.¹ Another eight-week randomized open-label study enrolled women aged 40–65 and used calorie restriction in both groups.² Neither design establishes fasting as necessary for menopause health.

What the studies actually tested

Study	Question	Limit
Premenopausal vs postmenopausal analysis¹	Short-term changes during a narrow eating window	Very small groups; menopause transition excluded
Middle-aged women in Taiwan²	Eight-hour eating window plus a low-calorie diet versus low-calorie diet	Short, open-label, single-center study
Climacteric women with obesity³	Body-composition and metabolic measures	Pre-post design; no universal or long-term conclusion

Medication and hypoglycemia boundary

People with diabetes may need medication and monitoring changes when fasting; NIDDK advises planning fasting with the health-care team.⁴ Low blood glucose can be dangerous and requires a condition-specific prevention and treatment plan.⁵

Questions before trying a schedule

What outcome is being measured, over what time and against what comparison?
Could medicines, pregnancy, eating-disorder history, illness or training load make restriction unsafe?
Can nutrition adequacy, strength, symptoms and adherence be monitored without treating scale weight as the only outcome?

Claim-level evidence

Sources and exact limits

Changes in body weight and metabolic risk during time restricted feeding in premenopausal versus postmenopausal women. Secondary intervention analysis. PMID 34478825. DOI 10.1016/j.exger.2021.111545. Design/population: Eight-week time-restricted-feeding study; 13 premenopausal and 19 postmenopausal women with obesity. Limit: Very small groups, short duration, and perimenopausal women excluded; not a menopause treatment trial. Disclosure: Authors reported no conflicts. Checked 2026-09-02.
Effect of time-restricted feeding on body composition and cardio-metabolic risk in middle-aged women in Taiwan. Randomized open-label trial. PMID 34763309. DOI 10.1016/j.nut.2021.111504. Design/population: Eight-week parallel-group intervention; Women aged 40–65 with elevated BMI or waist circumference. Limit: Short, single-center study with calorie restriction in both groups; menopause stage was not the treatment question. Disclosure: See full record for disclosures. Checked 2026-09-02.
Comparative study of time-restricted eating on body composition and metabolic parameters in climacteric women with obesity. Pre-post intervention study. PMID 39999466. Design/population: Comparative intervention analysis; Climacteric women with obesity. Limit: Not a long-term randomized menopause-outcomes trial; body-composition and metabolic endpoints do not establish universal benefit. Disclosure: See full record for disclosures. Checked 2026-09-02.
Fasting Safely with Diabetes. NIH professional clinical education. Design/population: Expert clinical guidance; People with diabetes considering fasting. Limit: Applies to diabetes-related fasting safety; it is not a general fasting protocol. Disclosure: Not reported or not applicable. Checked 2026-09-02.
Low Blood Glucose (Hypoglycemia). NIH government health guidance. Design/population: Clinical education page; People with diabetes and people at risk of hypoglycemia. Limit: Supports recognition and care context for low blood glucose; not a personalized treatment plan. Disclosure: Not reported or not applicable. Checked 2026-09-02.